The dysregulation of cyclin D1 transcription as well as assembly and hyperactivation of its cognate CDK result in uncontrolled cell growth, so cyclin D1 has been regarded as an oncogenic driver in cancers [3]. This evidence concerns the gene CCND1 and cancer.